4-year LUCENT data show mirikizumab reduces UC-related hospitalizations and surgeries, supporting durable remission and potential disease modification.
Fernando Magro, MD, PhD
Advertisement
Fernando Magro, MD, PhD, is head of clinical pharmacology at University Hospital São João.
Articles by Fernando Magro, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
2
SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes
3
REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System
4
FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy
5